Featuring Tim Lynch, Director, Project on Criminal Justice, Cato Institute; Michael Tanner, Senior Fellow, Cato Institute; and Matthew Feeney, Policy Analyst, Cato Institute; moderated by Peter Russo, Director, Congressional Affairs, Cato Institute.
A limited constitutional government calls for a rules-based, freemarket monetary system, not the topsy-turvy fiat dollar that now exists under central banking. This issue of the Cato Journal examines the case for alternatives to central banking and the reforms needed to move toward free-market money.
Two long wars, chronic deficits, the financial crisis, the costly drug war, the growth of executive power under Presidents Bush and Obama, and the revelations about NSA abuses, have given rise to a growing libertarian movement in our country – with a greater focus on individual liberty and less government power. David Boaz’s newly released The Libertarian Mind is a comprehensive guide to the history, philosophy, and growth of the libertarian movement, with incisive analyses of today’s most pressing issues and policies.
Featuring Thomas R. Saving, Medicare trustee, 2001-2007 and Stuart Guterman, Commonwealth Fund. Moderated by Michael F. Cannon, Cato Institute.
It is 2008. Research suggests the federal Medicare program spends as much as $100 billion per year on medical care that makes seniors no healthier or happier. Its payment system continues to reward low-quality and even harmful medical care. The trustees of the Medicare program have issued yet another annual report containing dire warnings about Medicare’s financial sustainability, including an unfunded liability of $86 trillion. The picture is far worse than it was when politicians were developing fundamental Medicare reforms 10 years ago. Yet politicians today seem uninterested. The president has proposed reforms that would barely slow the program’s growing dependence on general revenues-a proposal that Congress has largely ignored. Leading presidential candidates advocate tweaks-such as reducing payments for private plans and prescription drugs, or tying payments to quality measures-rather than fundamental reform. Come hear leading analysts discuss whether the case for Medicare reform is any less powerful now than in the past.